Literature DB >> 15309159

Folic Acid and Epilepsy.

Martha J. Morrell1.   

Abstract

Folic acid has been a topic of discussion within the epilepsy community for several decades. Folic acid was initially suspected to be epileptogenic (1), but that concern has been resolved, as research has demonstrated that folic acid in less than supraphysiologic concentrations does not promote seizures. Epileptologists are now concerned that folic acid may be too low in persons with epilepsy taking some antiepileptic drugs (AEDs). Low serum and red blood cell levels of folic acid in women of childbearing potential increase the risk of fetal birth defects. For men and women, low levels of folic acid are associated with elevated homocysteine and an increased risk for cardiovascular disease. A convincing argument now develops that routine folic acid supplementation is important for women and men receiving AEDs.

Entities:  

Year:  2002        PMID: 15309159      PMCID: PMC320966          DOI: 10.1111/j.1535-7597.2002.00017.x

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN: 1535-7511            Impact factor:   7.872


  35 in total

1.  Alteration of embryonic folate metabolism by valproic acid during organogenesis: implications for mechanism of teratogenesis.

Authors:  C Wegner; H Nau
Journal:  Neurology       Date:  1992-04       Impact factor: 9.910

2.  Practice parameter: management issues for women with epilepsy (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors: 
Journal:  Neurology       Date:  1998-10       Impact factor: 9.910

3.  Minimal compliance with the Department of Health recommendation for routine folate prophylaxis to prevent fetal neural tube defects.

Authors:  N A Clark; N M Fisk
Journal:  Br J Obstet Gynaecol       Date:  1994-08

4.  Impaired methionine synthesis and hypomethylation in rats exposed to valproate during gestation.

Authors:  E Alonso-Aperte; N Ubeda; M Achón; J Pérez-Miguelsanz; G Varela-Moreiras
Journal:  Neurology       Date:  1999-03-10       Impact factor: 9.910

5.  Hyperhomocysteinemia in children treated with sodium valproate and carbamazepine.

Authors:  A Verrotti; R Pascarella; D Trotta; T Giuva; G Morgese; F Chiarelli
Journal:  Epilepsy Res       Date:  2000-10       Impact factor: 3.045

6.  Folate levels and neural tube defects. Implications for prevention.

Authors:  L E Daly; P N Kirke; A Molloy; D G Weir; J M Scott
Journal:  JAMA       Date:  1995-12-06       Impact factor: 56.272

7.  Periconceptional use of multivitamins and the occurrence of neural tube defects.

Authors:  J Mulinare; J F Cordero; J D Erickson; R J Berry
Journal:  JAMA       Date:  1988-12-02       Impact factor: 56.272

8.  Recommendations on the use of folic acid supplementation to prevent the recurrence of neural tube defects. Clinical Teratology Committee, Canadian College of Medical Geneticists.

Authors:  M I Van Allen; F C Fraser; L Dallaire; J Allanson; D R McLeod; E Andermann; J M Friedman
Journal:  CMAJ       Date:  1993-11-01       Impact factor: 8.262

9.  Periconceptional folic acid exposure and risk of occurrent neural tube defects.

Authors:  M M Werler; S Shapiro; A A Mitchell
Journal:  JAMA       Date:  1993-03-10       Impact factor: 56.272

10.  Homocysteine metabolism in pregnancies complicated by neural-tube defects.

Authors:  J L Mills; J M McPartlin; P N Kirke; Y J Lee; M R Conley; D G Weir; J M Scott
Journal:  Lancet       Date:  1995-01-21       Impact factor: 79.321

View more
  11 in total

1.  Ameliorative effects of supplemental folinic acid on Lamotrigine-induced fetal malformations in the mouse.

Authors:  Y M Abdulrazzaq; M Shafiullah; J Kochyil; R Padmanabhan; S M A Bastaki
Journal:  Mol Cell Biochem       Date:  2018-01-23       Impact factor: 3.396

2.  Effect of Folic Acid Supplementation on Seizure Control in Epileptic Children Receiving Long Term Antiepileptic Therapy.

Authors:  Bindu Deopa; Manish Parakh; Pawan Dara; Vikas Payal; Kapil Chordiya; Ankit Panday; Sumeet Singh; Devesh Parashar
Journal:  Indian J Pediatr       Date:  2018-01-25       Impact factor: 1.967

Review 3.  A Clinical Approach to Catamenial Epilepsy: A Review.

Authors:  Samuel Frank; Nichole A Tyson
Journal:  Perm J       Date:  2020-12

4.  Use of Therapeutic Drug Monitoring, Electronic Health Record Data, and Pharmacokinetic Modeling to Determine the Therapeutic Index of Phenytoin and Lamotrigine.

Authors:  Lawrence C Ku; Huali Wu; Rachel G Greenberg; Kevin D Hill; Daniel Gonzalez; Christoph P Hornik; Alysha Berezny; Jeffrey T Guptill; Wenlei Jiang; Nan Zheng; Michael Cohen-Wolkowiez; Chiara Melloni
Journal:  Ther Drug Monit       Date:  2016-12       Impact factor: 3.118

5.  Effect of epilepsy on female fertility and reproductive abnormalities.

Authors:  Pratibha Singh; Manish Singh; Goutham Cugati; Ajai Kumar Singh
Journal:  J Hum Reprod Sci       Date:  2011-05

6.  Periconceptional folic acid and risk for neural tube defects among higher risk pregnancies.

Authors:  Julie M Petersen; Samantha E Parker; Corey M Benedum; Allen A Mitchell; Sarah C Tinker; Martha M Werler
Journal:  Birth Defects Res       Date:  2019-08-21       Impact factor: 2.661

Review 7.  Contemporary issues surrounding folic Acid fortification initiatives.

Authors:  Jeong-Hwa Choi; Zoe Yates; Martin Veysey; Young-Ran Heo; Mark Lucock
Journal:  Prev Nutr Food Sci       Date:  2014-12-31

8.  Teratogenicity of Antiepileptic Drugs.

Authors:  Betül Tekin Güveli; Rasim Özgür Rosti; Alper Güzeltaş; Elif Bahar Tuna; Dilek Ataklı; Serra Sencer; Ensar Yekeler; Hülya Kayserili; Ahmet Dirican; Nerses Bebek; Betül Baykan; Ayşen Gökyiğit; Candan Gürses
Journal:  Clin Psychopharmacol Neurosci       Date:  2017-02-28       Impact factor: 2.582

Review 9.  Hyperhomocysteinemia as a Risk Factor and Potential Nutraceutical Target for Certain Pathologies.

Authors:  Caterina Tinelli; Antonella Di Pino; Elena Ficulle; Serena Marcelli; Marco Feligioni
Journal:  Front Nutr       Date:  2019-04-24

Review 10.  Potentials of Musa Species Fruits against Oxidative Stress-Induced and Diet-Linked Chronic Diseases: In Vitro and In Vivo Implications of Micronutritional Factors and Dietary Secondary Metabolite Compounds.

Authors:  Barnabas Oluwatomide Oyeyinka; Anthony Jide Afolayan
Journal:  Molecules       Date:  2020-10-30       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.